Rivaroxaban and other novel oral anticoagulants: pharmacokinetics in healthy subjects, specific patient populations and relevance of coagulation monitoring | Thrombosis Journal | Full Text
Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial - The Lancet
Evolving Practice: Role of Anti-Factor Xa Testing in Modern Anticoagulation
Apixaban and Rivaroxaban Anti-Xa Level Monitoring Versus Standard Monitoring in Hospitalized Patients With Acute Kidney Injury | Semantic Scholar
Anesthesia&Analgesia on X: "Direct oral anticoagulant levels (apixaban and rivaroxaban) are important in certain situations: heparin anti-Xa activity could reliably detect apixaban, rivaroxaban, fondaparinux, and danaparoid #anticoagulant intensity ...
A tentative simple algorithm for the urgent screening of DOACs... | Download Scientific Diagram
Blood & Clots Series: How do I determine if my patient on a DOAC is still at increased risk of bleeding? - CanadiEM
Rivaroxaban: a fully-subsidised oral anticoagulant
Full article: Laboratory testing of rivaroxaban in routine clinical practice: When, how, and which assays
Evolving Practice: Role of Anti-Factor Xa Testing in Modern Anticoagulation
Biomedicines | Free Full-Text | Updates in Anticoagulation Therapy Monitoring
Xarelto® Rivaroxaban The first oral direct factor Xa inhibitor - ppt download
![Application of plasma metabolome for monitoring the effect of rivaroxaban in patients with nonvalvular atrial fibrillation [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2022/13853/1/fig-5-2x.jpg "Application of plasma metabolome for monitoring the effect of rivaroxaban in patients with nonvalvular atrial fibrillation [PeerJ]")
Application of plasma metabolome for monitoring the effect of rivaroxaban in patients with nonvalvular atrial fibrillation [PeerJ]
Biomedicines | Free Full-Text | Updates on Anticoagulation and Laboratory Tools for Therapy Monitoring of Heparin, Vitamin K Antagonists and Direct Oral Anticoagulants
Rivaroxaban Anticoagulant Monitoring | Cornell University College of Veterinary Medicine
Biomedicines | Free Full-Text | Updates on Anticoagulation and Laboratory Tools for Therapy Monitoring of Heparin, Vitamin K Antagonists and Direct Oral Anticoagulants
Rivaroxaban (XARELTO) | PPT
Reversal of Novel Oral Anticoagulants
Stroke Prevention in Atrial Fibrillation – The Use of NOACs in Everyday Clinical Practice | ECR Journal
A) Switching from VKAs to rivaroxaban. (B) Switching from rivaroxaban... | Download Scientific Diagram
Use of Novel Anticoagulants (NOACs) in Stroke
Practical guidance for using rivaroxaban in patients with atrial fibri | VHRM
Spot Checks or Monitoring of NOACs for Anticoagulation Status | AER Journal
New oral anticoagulants and regional anaesthesia - British Journal of Anaesthesia
